Pure Global

Lung Cancer Screening by Artificial Intelligence Device - Trial NCT06295497

Access comprehensive clinical trial information for NCT06295497 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese University of Hong Kong and is currently Not yet recruiting. The study focuses on Lung Cancer. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06295497
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06295497
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Lung Cancer Screening by Artificial Intelligence Device
Lung Cancer Screening in High Risk nonsmokErs by Artificial inteLligence Device

Study Focus

Lung Cancer

Lung-SIGHT

Interventional

device

Sponsor & Location

Chinese University of Hong Kong

Hong Kong, China

Timeline & Enrollment

N/A

Apr 01, 2024

Dec 31, 2027

1000 participants

Primary Outcome

The prevalence of early-staged lung cancer detected by first-round LDCT thorax (T0) in a high-risk non-smoker population

Summary

Lung cancer screening is currently not recommended in non-smokers due to paucity of evidence.
 Emerging evidence suggests that first-degree family history is a strong risk factor for lung
 cancer in Asian non-smokers. In Asia, lack of resource is a major challenge in successful
 implementation of lung cancer screening. Artificial intelligence (AI) is a promising tool to
 overcome this resource. In this study, we aim to study the clinical utility and demonstrate
 the feasibility of using an AI assisted programme for lung cancer screening in Asian
 non-smokers with a positive family history. This is a single-arm non-randomized lung cancer
 screening study. 1000 non-smokers, age 50 to 75 year old, with a first-degree family history
 of lung cancer, will be enrolled. Participants will undergo low does computed tomography
 (LDCT) of thorax and blood taking at enrolment. LDCT films will be interpreted by AI
 softwares for presence of lung nodules. Participants with lung nodules will be further
 investigated and followed up according to the risk of malignancy. The primary endpoint is the
 prevalence of early-staged lung cancer detected by first-round LDCT thorax in this
 population.

ICD-10 Classifications

Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm: Overlapping lesion of bronchus and lung

Data Source

ClinicalTrials.gov

NCT06295497

Device Trial